Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-DK-17-025

Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01- Clinical Trial Optional)

Closed on May 10, 2018.

Posted
February 15, 2018
Close date
May 10, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $548,534 in first-year total cost, median $548,534.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-9 (O4)]1

Most frequent institutions

  1. UNIVERSITY OF UTAH1
Competing awards under RFA-DK-17-025 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Development of concentrated, stable ultra fast-acting insulin formulation1R01DK120430-01CHOU, DANNY HUNG-CHIEHUNIVERSITY OF UTAH, UT$548,534ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
RFA-DK-17-025: Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01- Clinical Trial Optional) | ScienceDex | ConductScience